LUTREPULSE 3.2 MG
GONADORELIN ACETATE : 3.2 MG · DIN 02046202 · FERRING INC
Health Canada status: DORMANT
What is LUTREPULSE?
LUTREPULSE 3.2 MG contains GONADORELIN ACETATE : 3.2 MG. It is listed in the Health Canada Drug Product Database under DIN 02046202, held by FERRING INC, supplied as POWDER FOR SOLUTION for INTRAVENOUS ; SUBCUTANEOUS administration. Health Canada currently lists it as dormant, status dated 21-Apr-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LUTREPULSE used for?
LUTREPULSE (gonadorelin acetate) is indicated for the induction of ovulation in women with primary hypothalamic amenorrhea. Therapy is continued until the desired therapeutic result (follicle maturation and ovulation) is achieved. After ovulation, the therapy should be continued to support the corpus luteum function until the late luteal phase, until endogenous hCG of the implanted trophoblast maintains the function of the corpus luteum.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02046202 |
|---|---|
| Brand name | LUTREPULSE |
| Generic / active ingredient | GONADORELIN ACETATE : 3.2 MG |
| Manufacturer | FERRING INC |
| Strength | 3.2 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS ; SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | H01CA01 GONADORELIN |
| AHFS class | 68:18.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 21-Apr-2017 |
| Original market date | 1994-12-31 00:00:00 |
How is it stored and handled?
room temperature (15°-30°C) in the unopened package
How is it supplied?
Three vials of 3.2 mg of gonadorelin acetate as a lyophilized, sterile powder, Three 10 mL vial of 0.9% sodium chloride injection, 3 POD devices (POD with adhesive backing, supplied with a short needle and syringe); syringe for the reconstitution with sodium chloride
What can be used instead?
Other Canadian products sharing ATC code H01CA01 GONADORELIN. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LUTREPULSE PWS 0.8MG/VIAL | 0.8 MG | POWDER FOR SOLUTION | FERRING INC | CANCELLED POST MARKET | DIN 02046210 |
Who else supplies GONADORELIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GONADORELIN appears in 3 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.